Načítá se...
Screening for fetal chromosomal and subchromosomal disorders
Screening for fetal chromosomal disorders has evolved greatly over the last four decades. Initially, only maternal age-related risks of aneuploidy were provided to patients. This was followed by screening with maternal serum analytes and ultrasound markers, followed by the introduction and rapid upt...
Uloženo v:
| Vydáno v: | Semin Fetal Neonatal Med |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5891357/ https://ncbi.nlm.nih.gov/pubmed/29128491 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.siny.2017.10.006 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|